Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
Oral estramustine and oral etoposide for hormone-refractory prostate cancer. [electronic resource] by
- Dimopoulos, M A
- Panopoulos, C
- Bamia, C
- Deliveliotis, C
- Alivizatos, G
- Pantazopoulos, D
- Constantinidis, C
- Kostakopoulos, A
- Kastriotis, I
- Zervas, A
- Aravantinos, G
- Dimopoulos, C
Producer: 19971219
In:
Urology vol. 50
Availability: No items available.
|
|
16.
|
Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03). [electronic resource] by
- Bamias, A
- Dafni, U
- Karadimou, A
- Timotheadou, E
- Aravantinos, G
- Psyrri, A
- Xanthakis, I
- Tsiatas, M
- Koutoulidis, V
- Constantinidis, C
- Hatzimouratidis, C
- Samantas, E
- Visvikis, A
- Chrisophos, M
- Stravodimos, K
- Deliveliotis, C
- Eleftheraki, A
- Pectasides, D
- Fountzilas, G
- Dimopoulos, M A
Producer: 20130904
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 24
Availability: No items available.
|